Related Experiment Video
Updated: Feb 15, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Systemic lupus erythematosus with inflammatory bowel disease-ulcerative colitis: case report
H Elsayed Mansour1, S Gamal Arafa1, W Abdelfatah Shehata1
1Internal Medicine Department, Rheumatology Division, 68792 Ain Shams University Hospital , Abbassia, Cairo, Egypt.
This case report details a rare instance of a 30-year-old woman diagnosed with both systemic lupus erythematosus (SLE) and inflammatory bowel disease-ulcerative colitis (IBD-UC). The patient presented with pyoderma gangrenosum, vasculitis, and fulfilled classification criteria for both autoimmune conditions.
Area of Science:
- Rheumatology and Gastroenterology
- Autoimmune Diseases
- Clinical Case Study
Background:
- Co-occurrence of systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD) is uncommon.
- Understanding the interplay between these distinct autoimmune conditions is crucial for comprehensive patient management.
Observation:
- A 30-year-old female presented with pyoderma gangrenosum, indicative of underlying systemic inflammation.
- The patient exhibited symptoms suggestive of small-vessel vasculitis, including vision changes and digital ischemia.
- Recurrent rectal bleeding prompted investigation, leading to a diagnosis of ulcerative colitis (UC).
Findings:
- Colonoscopy and histopathology confirmed inflammatory bowel disease-ulcerative colitis (IBD-UC).
- The patient met the Systemic Lupus International Collaborating Clinics (SLICC) criteria for systemic lupus erythematosus (SLE), including oral ulcers, positive antinuclear antibodies, proteinuria, lupus anticoagulant, and low C3 complement.
- This case highlights the simultaneous presence of SLE and IBD-UC in a single patient.
Implications:
- This rare coexistence underscores the complex nature of autoimmune disorders.
- Clinicians should consider the possibility of multiple autoimmune conditions in patients with overlapping symptoms.
- Further research into the shared or distinct pathogenic mechanisms of SLE and IBD-UC may improve diagnostic and therapeutic strategies.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

